Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference38 articles.
1. Collaborators. PO. HBV progress towards coverage targets. 2021. 10-04/2022-02-06 http://cdafound.org/polaris-countries-dashboard/. Accessed 2019.
2. A global scientific strategy to cure hepatitis B;Revill;Lancet Gastroenterol Hepatol,2019
3. Getting to HBV cure: the promising paths forward;Fung;Hepatology,2022
4. Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections;Martinez;J Hepatol,2021
5. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load;Schuch;Gut,2019
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism;Gut;2024-05-02
2. Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression;Journal of Clinical and Translational Hepatology;2024-04-30
3. Oncostatin M for Anti-HBV Therapy: Can a Foe Be Turned Into a Friend?;Cellular and Molecular Gastroenterology and Hepatology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3